IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells
Background Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial...
Saved in:
Published in | Respiratory research Vol. 14; no. 1; p. 118 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
01.11.2013
|
Subjects | |
Online Access | Get full text |
ISSN | 1465-993X 1465-9921 1465-993X |
DOI | 10.1186/1465-9921-14-118 |
Cover
Abstract | Background
Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects.
Methods
Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22.
Results
Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics.
Conclusion
The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells. |
---|---|
AbstractList | Background
Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects.
Methods
Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22.
Results
Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics.
Conclusion
The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells. Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects. Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22. Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics. The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells. Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects.BACKGROUNDAllergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction. Epithelial-mesenchymal transition (EMT) may play a role in airway remodeling through the acquisition of a mesenchymal phenotype in airway epithelial cells. TGF-β1 is known to promote EMT; however, other cytokines expressed in severe asthma with extensive remodeling, such as IL-22, may also contribute to this process. In this study, we evaluated the contribution of IL-22 to EMT in primary bronchial epithelial cells from healthy and asthmatic subjects.Primary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22.METHODSPrimary bronchial epithelial cells were isolated from healthy subjects, mild asthmatics and severe asthmatics (n=5 patients per group). The mRNA and protein expression of epithelial and mesenchymal cell markers and EMT-associated transcription factors was evaluated following stimulation with TGF-β1, IL-22 and TGF-β1+IL-22.Primary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics.RESULTSPrimary bronchial epithelial cells stimulated with TGF-β1 underwent EMT, demonstrated by decreased expression of epithelial markers (E-cadherin and MUC5AC) and increased expression of mesenchymal markers (N-cadherin and vimentin) and EMT-associated transcription factors. IL-22 alone had no effect on epithelial or mesenchymal gene expression. However, IL-22+TGF-β1 promoted the expression of some EMT transcription factors (Snail1 and Zeb1) and led to a more profound cadherin shift, but only in cells obtained from severe asthmatics.The impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells.CONCLUSIONThe impact of IL-22 on airway epithelial cells depends on the cytokine milieu and the clinical phenotype of the patient. Further studies are required to determine the molecular mechanism of IL-22 and TGF-β1 cooperativity in driving EMT in primary human bronchial epithelial cells. |
ArticleNumber | 118 |
Author | Plante, Sophie Johnson, Jill R Eidelman, David Hamid, Qutayba Chakir, Jamila Risse, Paul-André Almaghlouth, Ibrahim Martin, James G Bazarbashi, Ahmad N Nishioka, Michiyoshi |
AuthorAffiliation | 1 Meakins-Christie Laboratories, McGill University, 3626 St. Urbain Street, Montréal, QC H2X 2P2, Canada 2 Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada |
AuthorAffiliation_xml | – name: 1 Meakins-Christie Laboratories, McGill University, 3626 St. Urbain Street, Montréal, QC H2X 2P2, Canada – name: 2 Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec, Québec, Canada |
Author_xml | – sequence: 1 givenname: Jill R surname: Johnson fullname: Johnson, Jill R organization: Meakins-Christie Laboratories, McGill University – sequence: 2 givenname: Michiyoshi surname: Nishioka fullname: Nishioka, Michiyoshi organization: Meakins-Christie Laboratories, McGill University – sequence: 3 givenname: Jamila surname: Chakir fullname: Chakir, Jamila organization: Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec – sequence: 4 givenname: Paul-André surname: Risse fullname: Risse, Paul-André organization: Meakins-Christie Laboratories, McGill University – sequence: 5 givenname: Ibrahim surname: Almaghlouth fullname: Almaghlouth, Ibrahim organization: Meakins-Christie Laboratories, McGill University – sequence: 6 givenname: Ahmad N surname: Bazarbashi fullname: Bazarbashi, Ahmad N organization: Meakins-Christie Laboratories, McGill University – sequence: 7 givenname: Sophie surname: Plante fullname: Plante, Sophie organization: Centre de recherche de l'institut universitaire de cardiologie et de pneumologie de Québec – sequence: 8 givenname: James G surname: Martin fullname: Martin, James G organization: Meakins-Christie Laboratories, McGill University – sequence: 9 givenname: David surname: Eidelman fullname: Eidelman, David organization: Meakins-Christie Laboratories, McGill University – sequence: 10 givenname: Qutayba surname: Hamid fullname: Hamid, Qutayba email: qutayba.hamid@mcgill.ca organization: Meakins-Christie Laboratories, McGill University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24283210$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1rGzEQFSElX-29p6JjL0pH8mpXewmEkKQBQy8J5CZk7ThW2JVcSVvw38oPyW-qFjvBLbSnGUbvzdN7c0oOffBIyGcO55yr-huvasnaVnDGK1YmB-RkN5o9Hu71x-Q0pWcA3qhGHpFjUQk1ExxOSLibMyGoDT5HtxgzJpoDvb-9Ya8vnA3YOZOxo7h2eYW9M32ZJfR2tRlMT3M0PrnsgqfOU5PyajDZWbqIoUAKeo9ILfZ9-kg-LE2f8NOunpGHm-v7q-9s_uP27upyzmzFW8VM17a1ABCopLRNB9iBkqVKjgtlbb3slDSVlTNZjDStsGCFRIC24wIlzM7IxXbvelwUFxaLP9PrdXSDiRsdjNN_vni30k_hl654U0NblwVfdwti-DliynpwabJgPIYx6ZJtJQFATVpf9rXeRd5SLgDYAmwMKUVcvkM46OmQ0zapp0OWbpoUSv0XxbpspqTLb13_PyLfElPR8E8Y9XMYoy9Z_5vzGwZ1sn4 |
CitedBy_id | crossref_primary_10_1080_17476348_2016_1174580 crossref_primary_10_3389_fimmu_2021_601842 crossref_primary_10_1002_jcp_26284 crossref_primary_10_1016_j_pedneo_2017_11_020 crossref_primary_10_3892_ol_2019_10972 crossref_primary_10_3390_biom11020310 crossref_primary_10_1186_s12931_017_0563_4 crossref_primary_10_1183_16000617_0112_2021 crossref_primary_10_1016_j_jaci_2016_09_022 crossref_primary_10_1007_s10753_015_0123_3 crossref_primary_10_1016_j_clim_2024_110228 crossref_primary_10_1080_21645515_2018_1509649 crossref_primary_10_1002_eji_201646723 crossref_primary_10_1007_s11033_020_05439_x crossref_primary_10_1038_aps_2014_91 crossref_primary_10_1097_ACI_0000000000000701 crossref_primary_10_1371_journal_pone_0122372 crossref_primary_10_1038_s42003_021_01797_9 crossref_primary_10_1016_j_yexcr_2018_12_017 crossref_primary_10_1002_ptr_7774 crossref_primary_10_3892_mmr_2014_2941 crossref_primary_10_1093_jpp_rgae064 crossref_primary_10_1002_1878_0261_12598 crossref_primary_10_1371_journal_pone_0184386 crossref_primary_10_1186_s12860_021_00356_8 crossref_primary_10_1016_j_ebiom_2018_06_032 crossref_primary_10_1371_journal_pone_0149180 crossref_primary_10_3389_fcimb_2021_739874 crossref_primary_10_1007_s10753_022_01621_4 crossref_primary_10_1177_1535370215597194 crossref_primary_10_3390_jcm5070063 crossref_primary_10_1111_cea_12712 crossref_primary_10_1007_s40629_015_0039_3 crossref_primary_10_1016_j_cellsig_2021_110123 crossref_primary_10_1186_s12931_018_0834_8 crossref_primary_10_5812_ijp_114153 crossref_primary_10_12659_MSM_899955 crossref_primary_10_1186_s12931_014_0146_6 crossref_primary_10_1016_j_alit_2018_10_002 crossref_primary_10_1111_cei_13337 crossref_primary_10_1007_s10753_023_01847_w crossref_primary_10_1080_02770903_2022_2155186 crossref_primary_10_3389_fimmu_2022_1040442 crossref_primary_10_1513_AnnalsATS_201407_304AW crossref_primary_10_1134_S2079086418050055 crossref_primary_10_1016_j_taap_2022_116044 crossref_primary_10_1002_jcp_24832 crossref_primary_10_1165_rcmb_2016_0307TR crossref_primary_10_3892_mmr_2015_4518 crossref_primary_10_1089_jir_2021_0222 crossref_primary_10_1186_s12890_021_01698_x crossref_primary_10_3389_falgy_2022_806391 crossref_primary_10_1007_s00018_020_03693_7 crossref_primary_10_3389_falgy_2020_628381 crossref_primary_10_1111_all_15889 crossref_primary_10_1016_j_jss_2015_02_062 crossref_primary_10_15369_sujms_28_101 crossref_primary_10_1038_s41598_024_66068_z crossref_primary_10_3346_jkms_2024_39_e266 crossref_primary_10_1016_j_cytogfr_2014_04_005 crossref_primary_10_1016_j_jaci_2017_04_005 crossref_primary_10_1007_s15007_015_0750_x crossref_primary_10_1016_j_smim_2019_101346 crossref_primary_10_1111_cea_12451 crossref_primary_10_1099_jmm_0_000581 |
Cites_doi | 10.1038/nri2870 10.1159/000250438 10.1186/1465-9921-10-100 10.1038/ni.1892 10.1080/08820130903062756 10.1172/JCI200320530 10.1074/jbc.M204204200 10.1016/j.immuni.2012.05.028 10.1164/rccm.200811-1730OC 10.1016/j.jaci.2009.02.024 10.1371/journal.pone.0016175 10.1016/j.jaci.2005.06.011 10.1016/S0140-6736(00)03496-6 10.1007/s00281-009-0189-9 10.1093/intimm/dxr001 10.1136/thx.24.2.176 10.1096/fj.12-208033 10.1186/1465-9921-7-135 10.1016/j.jaci.2010.12.1117 10.1172/JCI39104 10.1016/j.jaci.2007.11.023 10.1038/ncb1905 10.1002/eji.200838655 10.1016/j.cyto.2010.02.003 10.1164/rccm.200909-1448OC 10.1056/NEJMoa0805435 10.1164/rccm.200209-1030OC 10.1007/s10875-010-9368-7 10.1164/ajrccm.162.6.ats9-00 10.1186/1755-1536-3-2 10.1016/j.devcel.2008.05.009 10.1164/ajrccm/148.5.1220 10.1067/mai.2001.115624 10.1183/09031936.00138707 10.1038/mi.2012.76 10.1165/rcmb.2008-0449OC 10.1016/j.jaci.2012.09.036 10.1159/000318854 10.1165/ajrcmb.27.2.4779 10.1007/s11926-007-0075-1 10.1074/jbc.M007837200 10.1165/ajrcmb.15.3.8810634 10.1165/rcmb.2010-0027TR |
ContentType | Journal Article |
Copyright | Johnson et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright © 2013 Johnson et al.; licensee BioMed Central Ltd. 2013 Johnson et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: Johnson et al.; licensee BioMed Central Ltd. 2013 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright © 2013 Johnson et al.; licensee BioMed Central Ltd. 2013 Johnson et al.; licensee BioMed Central Ltd. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1186/1465-9921-14-118 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1465-993X |
EndPage | 118 |
ExternalDocumentID | PMC4176096 24283210 10_1186_1465_9921_14_118 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Canadian Institutes of Health Research |
GroupedDBID | --- 0R~ 29P 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR IPNFZ ITC KQ8 M1P M48 O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c4198-ad9962002e855c7d0ed0857d051eb8cc6fd85a4c535832792c0c25e009d12e503 |
IEDL.DBID | M48 |
ISSN | 1465-993X 1465-9921 |
IngestDate | Thu Aug 21 14:17:09 EDT 2025 Thu Sep 04 17:43:42 EDT 2025 Thu Apr 03 07:04:44 EDT 2025 Tue Jul 01 02:43:04 EDT 2025 Thu Apr 24 22:51:15 EDT 2025 Sat Sep 06 07:29:01 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Airway Smooth Muscle Severe Asthmatic Allergic Asthma Bronchial Epithelial Cell Airway Epithelial Cell |
Language | English |
License | This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4198-ad9962002e855c7d0ed0857d051eb8cc6fd85a4c535832792c0c25e009d12e503 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1465-9921-14-118 |
PMID | 24283210 |
PQID | 1464500080 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4176096 proquest_miscellaneous_1464500080 pubmed_primary_24283210 crossref_primary_10_1186_1465_9921_14_118 crossref_citationtrail_10_1186_1465_9921_14_118 springer_journals_10_1186_1465_9921_14_118 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20131101 |
PublicationDateYYYYMMDD | 2013-11-01 |
PublicationDate_xml | – month: 11 year: 2013 text: 20131101 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Respiratory research |
PublicationTitleAbbrev | Respir Res |
PublicationTitleAlternate | Respir Res |
PublicationYear | 2013 |
Publisher | BioMed Central |
Publisher_xml | – name: BioMed Central |
References | Y Zhao (1425_CR6) 2010; 151 F Goulet (1425_CR26) 1996; 15 SV Kotenko (1425_CR40) 2001; 276 B Schnyder (1425_CR30) 2010; 50 MS Dunnill (1425_CR16) 1969; 24 T Vincent (1425_CR43) 2009; 11 D Lejeune (1425_CR41) 2002; 277 LC Borish (1425_CR7) 2001; 107 C Blaschitz (1425_CR12) 2010; 30 AM Hanash (1425_CR36) 2012; 37 Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions (1425_CR25) 2000; 162 Y Chang (1425_CR28) 2012; 26 AM Doerner (1425_CR33) 2009; 10 A Rosendahl (1425_CR42) 2002; 27 CK Wong (1425_CR5) 2009; 38 D Pennino (1425_CR35) 2013; 131 W Al-Ramli (1425_CR3) 2009; 123 LA Zenewicz (1425_CR14) 2011; 23 DM Bullens (1425_CR4) 2006; 7 L Benayoun (1425_CR18) 2003; 167 R Kalluri (1425_CR20) 2003; 112 C Pepe (1425_CR19) 2005; 116 TL Hackett (1425_CR32) 2009; 180 HY Kim (1425_CR1) 2010; 11 J Zhao (1425_CR23) 2012; 6 E Lubberts (1425_CR11) 2010; 32 J Yang (1425_CR44) 2008; 14 FJ Rodriguez (1425_CR37) 1826; 2012 J Corren (1425_CR8) 2010; 181 ME Darveau (1425_CR27) 2008; 121 S Kamitani (1425_CR38) 2011; 155 CM Lloyd (1425_CR2) 2010; 10 ED Bateman (1425_CR24) 2008; 31 K Kuwano (1425_CR17) 1993; 148 JR Johnson (1425_CR21) 2011; 6 Y Chang (1425_CR29) 2011; 127 E Fitch (1425_CR13) 2007; 9 MJ Leckie (1425_CR9) 2000; 356 LA Zenewicz (1425_CR15) 2008; 38 J Camara (1425_CR34) 2010; 3 P Nair (1425_CR10) 2009; 360 R Halwani (1425_CR31) 2011; 44 R Kalluri (1425_CR22) 2009; 119 IH Heijink (1425_CR39) 2010; 42 |
References_xml | – volume: 10 start-page: 838 year: 2010 ident: 1425_CR2 publication-title: Nat Rev Immunol doi: 10.1038/nri2870 – volume: 151 start-page: 297 year: 2010 ident: 1425_CR6 publication-title: Int Arch Allergy Immunol doi: 10.1159/000250438 – volume: 10 start-page: 100 year: 2009 ident: 1425_CR33 publication-title: Respir Res doi: 10.1186/1465-9921-10-100 – volume: 11 start-page: 577 year: 2010 ident: 1425_CR1 publication-title: Nat Immunol doi: 10.1038/ni.1892 – volume: 38 start-page: 652 year: 2009 ident: 1425_CR5 publication-title: Immunol Invest doi: 10.1080/08820130903062756 – volume: 112 start-page: 1776 year: 2003 ident: 1425_CR20 publication-title: J Clin Investig doi: 10.1172/JCI200320530 – volume: 277 start-page: 33676 year: 2002 ident: 1425_CR41 publication-title: J Biol Chem doi: 10.1074/jbc.M204204200 – volume: 37 start-page: 339 year: 2012 ident: 1425_CR36 publication-title: Immunity doi: 10.1016/j.immuni.2012.05.028 – volume: 180 start-page: 122 year: 2009 ident: 1425_CR32 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200811-1730OC – volume: 123 start-page: 1185 year: 2009 ident: 1425_CR3 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2009.02.024 – volume: 6 start-page: e16175 year: 2011 ident: 1425_CR21 publication-title: PLoS One doi: 10.1371/journal.pone.0016175 – volume: 2012 start-page: 23 year: 1826 ident: 1425_CR37 publication-title: Biochim Biophys Acta – volume: 116 start-page: 544 year: 2005 ident: 1425_CR19 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2005.06.011 – volume: 356 start-page: 2144 year: 2000 ident: 1425_CR9 publication-title: Lancet doi: 10.1016/S0140-6736(00)03496-6 – volume: 32 start-page: 43 year: 2010 ident: 1425_CR11 publication-title: Semin Immunopathol doi: 10.1007/s00281-009-0189-9 – volume: 23 start-page: 159 year: 2011 ident: 1425_CR14 publication-title: Int Immunol doi: 10.1093/intimm/dxr001 – volume: 24 start-page: 176 year: 1969 ident: 1425_CR16 publication-title: Thorax doi: 10.1136/thx.24.2.176 – volume: 26 start-page: 5152 year: 2012 ident: 1425_CR28 publication-title: FASEB J doi: 10.1096/fj.12-208033 – volume: 7 start-page: 135 year: 2006 ident: 1425_CR4 publication-title: Respir Res doi: 10.1186/1465-9921-7-135 – volume: 127 start-page: 1046 year: 2011 ident: 1425_CR29 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2010.12.1117 – volume: 119 start-page: 1420 year: 2009 ident: 1425_CR22 publication-title: J Clin Investig doi: 10.1172/JCI39104 – volume: 121 start-page: 692 year: 2008 ident: 1425_CR27 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2007.11.023 – volume: 11 start-page: 943 year: 2009 ident: 1425_CR43 publication-title: Nat Cell Biol doi: 10.1038/ncb1905 – volume: 38 start-page: 3265 year: 2008 ident: 1425_CR15 publication-title: Eur J Immunol doi: 10.1002/eji.200838655 – volume: 50 start-page: 220 year: 2010 ident: 1425_CR30 publication-title: Cytokine doi: 10.1016/j.cyto.2010.02.003 – volume: 181 start-page: 788 year: 2010 ident: 1425_CR8 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200909-1448OC – volume: 360 start-page: 985 year: 2009 ident: 1425_CR10 publication-title: N Engl J Med doi: 10.1056/NEJMoa0805435 – volume: 167 start-page: 1360 year: 2003 ident: 1425_CR18 publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200209-1030OC – volume: 30 start-page: 196 year: 2010 ident: 1425_CR12 publication-title: J Clin Immunol doi: 10.1007/s10875-010-9368-7 – volume: 162 start-page: 2341 year: 2000 ident: 1425_CR25 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.162.6.ats9-00 – volume: 3 start-page: 2 year: 2010 ident: 1425_CR34 publication-title: Fibrogenesis & Tissue Repair doi: 10.1186/1755-1536-3-2 – volume: 14 start-page: 818 year: 2008 ident: 1425_CR44 publication-title: Dev Cell doi: 10.1016/j.devcel.2008.05.009 – volume: 148 start-page: 1220 year: 1993 ident: 1425_CR17 publication-title: Am Rev Respir Dis doi: 10.1164/ajrccm/148.5.1220 – volume: 107 start-page: 963 year: 2001 ident: 1425_CR7 publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.115624 – volume: 31 start-page: 143 year: 2008 ident: 1425_CR24 publication-title: Eur Respir J doi: 10.1183/09031936.00138707 – volume: 6 start-page: 335 issue: 2 year: 2012 ident: 1425_CR23 publication-title: Mucosal Immunol doi: 10.1038/mi.2012.76 – volume: 42 start-page: 69 year: 2010 ident: 1425_CR39 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2008-0449OC – volume: 131 start-page: 562 year: 2013 ident: 1425_CR35 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.09.036 – volume: 155 start-page: 119 year: 2011 ident: 1425_CR38 publication-title: Int Arch Allergy Immunol doi: 10.1159/000318854 – volume: 27 start-page: 160 year: 2002 ident: 1425_CR42 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/ajrcmb.27.2.4779 – volume: 9 start-page: 461 year: 2007 ident: 1425_CR13 publication-title: Curr Rheumatol Rep doi: 10.1007/s11926-007-0075-1 – volume: 276 start-page: 2725 year: 2001 ident: 1425_CR40 publication-title: J Biol Chem doi: 10.1074/jbc.M007837200 – volume: 15 start-page: 312 year: 1996 ident: 1425_CR26 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/ajrcmb.15.3.8810634 – volume: 44 start-page: 127 year: 2011 ident: 1425_CR31 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2010-0027TR |
SSID | ssj0017875 |
Score | 2.324845 |
Snippet | Background
Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction.... Allergic asthma is characterized by airway inflammation in response to antigen exposure, leading to airway remodeling and lung dysfunction.... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 118 |
SubjectTerms | Adolescent Adult Aged Asthma - metabolism Asthma - pathology Asthma - physiopathology Biopsy Bronchi - drug effects Bronchi - pathology Bronchi - physiopathology Cadherins - metabolism Case-Control Studies Cells, Cultured Epithelial Cells - drug effects Epithelial Cells - pathology Epithelial Cells - physiology Epithelial-Mesenchymal Transition - drug effects Epithelial-Mesenchymal Transition - physiology Female Humans In Vitro Techniques Interleukin-22 Interleukins - pharmacology Interleukins - physiology Male Medicine Medicine & Public Health Middle Aged Mucin 5AC - metabolism Phenotype Pneumology/Respiratory System RNA, Messenger - metabolism Severity of Illness Index Transforming Growth Factor beta1 - pharmacology Transforming Growth Factor beta1 - physiology Young Adult |
SummonAdditionalLinks | – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9wwELYoSFUvCOhreclIvYBkETt-5YhW3QKCnkDiFtmOV4u0TRAJB_4WP4TfxIw3u2JLW6m3yBlbSeabeMbzIuRbZk3MnQlM6yxHAyWwIkTHZOF4sGPnxwZzhy9_6tNreX6jbvrzDsyFee2_51YfgyArVhSCMy4ZjLwjawp-u4jloR4u_AUAOzV3Qv5h1vKm80aTfBsQ-ZtXNG02ow2y3muJ9GTG1k2yEust8v6y94N_JM3ZBROCpjhzbFgVW9o19OrHiD0_cZayQUCTpPEOMy6mADEYawGPk8dfsGyH-1MK1aK3NXVtN0l1W6m_b2oMfZ6-mkjxZL_9RK5H36-Gp6xvncCC5IVlrgI7BuMvolUqmCqLFZayr0AEo7ch6HFllZNB5QpE2hQiZEGoCApXxUVUWf6ZrNZNHb8SqmXwQhjvpTfSVsY77nleOczRNdHoATmef9sy9HXFsb3FtEz2hdVoXagSuQFXODIgh4sZd7OaGv-gPZizqwTg4zu7OjYPLVJKlTTeAfkyY99iNSFTBya4Y5YYuyDAotrLd-rbSSquLbnRYNYNyNEcAmUv1e1fH3L7f4h3yAeBLTVSPuMuWe3uH-IeKDad30-YfgE3gvFl priority: 102 providerName: Springer Nature |
Title | IL-22 contributes to TGF-β1-mediated epithelial-mesenchymal transition in asthmatic bronchial epithelial cells |
URI | https://link.springer.com/article/10.1186/1465-9921-14-118 https://www.ncbi.nlm.nih.gov/pubmed/24283210 https://www.proquest.com/docview/1464500080 https://pubmed.ncbi.nlm.nih.gov/PMC4176096 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfYJiFe0MbXwkZlJF5AMsuHP5IHhLpqZVRsQrBKfYtsx1UnlWQ0mcT-Lf4Q_qbduUlH2cZToosdOb47-S539ztC3oSpcolWlkkZJuigWJZZpxnPdGTTqTZThbXDJ6fyeMxHEzG5KY9uN7C-07XDflLjxfz9r59XH0HhP3iFT-UBKLtgWRZHLOIMKBtky0eLMJGP38QUQDRFF6i8YxbCAnPfuCdcP6NuGZ638yf_CaL6s2m4TR63RiXtL6Vghzxw5RPy8KQNmz8l1ecvLI6pT0vH_laupk1Fzz4N2Z_fEfPFI2B4UneBBRpzkEig1SC-s6sf8NoGjzOf2UXPS6rrZuZhXqlZVCVmSs__mkgxEFA_I-Ph0dngmLWdFpjlUZYyXYDbg-kaLhXCqiJ0BSLfF6CxzqTWymmRCs2tSARskMpiG9pYOLDPiih2Ikyek82yKt0uoZJbE8fKGG4UTwtldGSipNBY0quckgE56PY2ty0MOXbDmOfeHUklOiMiR8bAHVIC8nY142IJwfGfsa87duWgJ_jNunTVZY0jufAGckBeLNm3elvH94CoNcauBiAG9_qT8nzmsbh5pCR4gQF514lA3snwvYt8ee8C9sijGNtt-FrHfbLZLC7dKzB6GtMjG2qiemSr3x99H8H18Oj06zegDuSg538k9Ly0XwNsQQH_ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9swDBa2Duh2GfZe9qoK9NICQi1ZLx-HYFnaJT2lQG-GJCtIgcwuavewv7Ufst80UnGCZu0G7GbIlGCLJESK5EdCDjJrYu5MYFpnOToogRUhOiYLx4OdOz83WDs8PdPjc3l6oS76-w6shbkdv-dWH4MiK1YUgjMuGYw8JI8wboko-UM93MQLQOzUOgh5z6ztQ-eOJXk3IfKPqGg6bEbPyNPeSqSfV2x9Th7E-gXZnfZx8JekOZkwIWjKM8eGVbGlXUNnX0fs10_OUjUIWJI0XmHFxRJEDMZakMfFj--wbIfnU0rVopc1dW23SLit1F83NaY-L29NpHiz374i56Mvs-GY9a0TWIDtscxV4Mdg_kW0SgVTZbFCKPsKVDB6G4KeV1Y5GVSuQKVNIUIWhIpgcFVcRJXlr8lO3dTxLaFaBi-E8V56I21lvOOe55XDGl0TjR6Q4_XelqHHFcf2Fssy-RdWo3ehSuQGPOHIgBxuZlytMDX-Qbu_ZlcJgo__7OrY3LRIKVWyeAfkzYp9m9WETB2Y4I3ZYuyGAEG1t9_Ul4sEri250eDWDcjRWgTKXqvbv37ku_8h3iOPx7PppJycnH17T54IbK-Rahs_kJ3u-iZ-BCOn85-SfP8Guhb0VA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEBZtAqGXkL43fanQSwtiLVkvH5e222SbhEITyM3otWxgay-xc8jfyg_pb4pGtpdu0xZ6M9JI2J4ZNKOZ-Qahd5lWITfKESmzHBwURwoXDOGFoU7PjZ0rqB0-PpEHZ3x2Ls77C7dmyHYfQpJdTQOgNFXteOXnnYprOY7qLUhRMEooJ3HkPtrWoiii87U9mcy-z9ZxhCiOYghO_mHd5mF0x8K8myj5W7Q0HULTPbTbW4940rH7IboXqkdo57iPjz9G9eERYQyn_HNoZBUa3Nb49MuU_LyhJFWJRAsThxVUYiyj6MWxJsrp4vpH3LaFcyulcOGLCpumXSQ8V2wv6wpSope_LMRw4988QWfTz6cfD0jfUoE4TgtNjI_-DeRlBC2EUz4LHiDufVTNYLVzcu61MNyJXERVVwVzmWMiREPMUxZElj9FW1VdhecIS-4sY8pabhXXXllDLc29gdpdFZQcofHwb0vX441D24tlmfwOLcHrECVwIz7ByAi9X69YdVgb_6B9O7CrjAoB32yqUF81QMlFsoRH6FnHvvVujKfOTHFGbTB2TQBg25sz1cUigW5zqmR090bowyACZa_tzV9fcv9_iN-gnW-fpuXR4cnXF-gBg64bqeTxJdpqL6_Cq2j7tPZ1L-C3Xan-Eg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IL-22+contributes+to+TGF-%CE%B21-mediated+epithelial-mesenchymal+transition+in+asthmatic+bronchial+epithelial+cells&rft.jtitle=Respiratory+research&rft.au=Johnson%2C+Jill+R&rft.au=Nishioka%2C+Michiyoshi&rft.au=Chakir%2C+Jamila&rft.au=Risse%2C+Paul-Andr%C3%A9&rft.date=2013-11-01&rft.eissn=1465-993X&rft.volume=14&rft.spage=118&rft_id=info:doi/10.1186%2F1465-9921-14-118&rft_id=info%3Apmid%2F24283210&rft.externalDocID=24283210 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon |